Exact Mass: 753.591

Exact Mass Matches: 753.591

Found 500 metabolites which its exact mass value is equals to given mass value 753.591, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PE(20:2(11Z,14Z)/P-18:1(11Z))

(2-aminoethoxy)[(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(20:2(11Z,14Z)/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/P-18:1(11Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(20:2(11Z,14Z)/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/P-18:1(11Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(20:2(11Z,14Z)/P-18:1(9Z))

(2-aminoethoxy)[(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(20:2(11Z,14Z)/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/P-18:1(9Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(20:3(5Z,8Z,11Z)/P-18:0)

(2-aminoethoxy)[(2R)-3-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-2-[(1Z)-octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(20:3(5Z,8Z,11Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:3(5Z,8Z,11Z)/P-18:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The mead acid moiety is derived from fish oils, liver and kidney, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(20:3(5Z,8Z,11Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:3(5Z,8Z,11Z)/P-18:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The mead acid moiety is derived from fish oils, liver and kidney, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(20:3(8Z,11Z,14Z)/P-18:0)

(2-aminoethoxy)[(2R)-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-2-[(1Z)-octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(20:3(8Z,11Z,14Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:3(8Z,11Z,14Z)/P-18:0), in particular, consists of one chain of homo-g-linolenic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The homo-g-linolenic acid moiety is derived from fish oils, liver and kidney, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(P-18:1(11Z)/P-18:1(11Z))

(2R)-2,3-Bis[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H84NO6P (753.6036)


PC(P-18:1(11Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/P-18:1(11Z)), in particular, consists of two chains of plasmalogen 18:1n7 at the C-1 and C-2 positions. The plasmalogen 18:1n7 moieties are derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(11Z)/P-18:1(9Z))

(2R)-3-[(1Z,11Z)-Octadeca-1,11-dien-1-yloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H84NO6P (753.6036)


PC(P-18:1(11Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/P-18:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(9Z)/P-18:1(11Z))

(2R)-2-[(1Z,11Z)-Octadeca-1,11-dien-1-yloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H84NO6P (753.6036)


PC(P-18:1(9Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/P-18:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(9Z)/P-18:1(9Z))

(2R)-2,3-Bis[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H84NO6P (753.6036)


PC(P-18:1(9Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/P-18:1(9Z)), in particular, consists of two chains of plasmalogen 18:1n9 at the C-1 and C-2 positions. The plasmalogen 18:1n9 moieties are derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:0/20:3(5Z,8Z,11Z))

(2-aminoethoxy)[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(1Z)-octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(P-18:0/20:3(5Z,8Z,11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of mead acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the mead acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/20:3(5Z,8Z,11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of mead acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the mead acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:0/20:3(8Z,11Z,14Z))

(2-aminoethoxy)[(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-3-[(1Z)-octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(P-18:0/20:3(8Z,11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/20:3(8Z,11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(11Z)/20:2(11Z,14Z))

(2-aminoethoxy)[(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(P-18:1(11Z)/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(P-18:1(9Z)/20:2(11Z,14Z))

(2-aminoethoxy)[(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


PE(P-18:1(9Z)/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(9Z)/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

Phosphatidylethanolamine alkyl 18:0-20:4

Phosphatidylethanolamine alkyl 18:0-20:4

C43H80NO7P (753.5672)


   

Phosphatidylethanolamine alkenyl 18:0-20:3

Phosphatidylethanolamine alkenyl 18:0-20:3

C43H80NO7P (753.5672)


   

Phosphatidylethanolamine alkyl 16:0-22:4

Phosphatidylethanolamine alkyl 16:0-22:4

C43H80NO7P (753.5672)


   

(2RS,3SR,4E,8E)-1-O-(beta-D-glucopyranosyl)-3-hydroxy-2-{[(2SR,3E)-2-hydroxy-3-octadecenoyl]amino}-9-methyloctadeca-4,8-diene

(2RS,3SR,4E,8E)-1-O-(beta-D-glucopyranosyl)-3-hydroxy-2-{[(2SR,3E)-2-hydroxy-3-octadecenoyl]amino}-9-methyloctadeca-4,8-diene

C43H79NO9 (753.5755)


   

(3E,4E)-1-(beta-D-glucopyranosyloxy)-3-hydroxy-2-[(2-hydroxyoctadecanyloxy)amino]-10-methyl-3,4,9-octadecatriene

(3E,4E)-1-(beta-D-glucopyranosyloxy)-3-hydroxy-2-[(2-hydroxyoctadecanyloxy)amino]-10-methyl-3,4,9-octadecatriene

C43H79NO9 (753.5755)


   

1-O-(beta-D-glucopyranosyl)-(2S,3R,4E)-2-[(2R,13Z)-2-hydroxy-13-docosenoylamino]-1,3-dihydroxy-4-hexadecene

1-O-(beta-D-glucopyranosyl)-(2S,3R,4E)-2-[(2R,13Z)-2-hydroxy-13-docosenoylamino]-1,3-dihydroxy-4-hexadecene

C44H83NO8 (753.6118)


   

norbatzelladine A

norbatzelladine A

C41H71N9O4 (753.5629)


   

asperamide B

asperamide B

C43H79NO9 (753.5755)


A glucosylceramide found in Penicillium commune.

   

Cerebroside C

N-(2-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine

C43H79NO9 (753.5755)


   
   

(2-aminoethoxy)[2-[icosa-5.8.11-trienoyloxy]-3-[octadec-1-en-1-yloxy]propoxy]phosphinic acid

(2-aminoethoxy)[2-[icosa-5.8.11-trienoyloxy]-3-[octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H80NO7P (753.5672)


   

GlcCer(d14:1/24:1)

N-(15Z-tetracosenoyl)-1-beta-glucosyl-tetradecasphing-4-enine

C44H83NO8 (753.6118)


   

GlcCer(d14:2(4E,6E)/24:0)

N-(tetracosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine

C44H83NO8 (753.6118)


   

GlcCer(d16:2(4E,6E)/22:0)

N-(docosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine

C44H83NO8 (753.6118)


   

PC(O-15:0/20:4)

3,5,8-Trioxa-4-phosphaoctacosa-13,16,19,22-tetraen-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[(pentadecyloxy)methyl]-, inner salt, 4-oxide, [R-(all-Z)]-

C43H80NO7P (753.5672)


   

PC(O-15:0/20:4)[U]

3,5,8-Trioxa-4-phosphaoctacosa-13,16,19,22-tetraen-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[(pentadecyloxy)methyl]-, inner salt, 4-oxide, (all-Z)-

C43H80NO7P (753.5672)


   

1-hexadecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine

1-hexadecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine

C44H84NO6P (753.6036)


   

PE(38:3)

1-(1-Enyl-stearoyl)-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

PE(O-16:0/22:4(7Z,10Z,13Z,16Z))

1-hexadecyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

PE(O-20:0/18:4(6Z,9Z,12Z,15Z))

1-eicosyl-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

PE(O-18:0/20:4(5Z,8Z,11Z,14Z))

1-octadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

PE(P-20:0/18:3(6Z,9Z,12Z))

1-(1Z-eicosenyl)-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

PE(P-20:0/18:3(9Z,12Z,15Z))

1-(1Z-eicosenyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

PC O-35:4

1-pentadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine

C43H80NO7P (753.5672)


   

PC dO-36:4

1-hexadecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine

C44H84NO6P (753.6036)


   

PE O-38:4

1-(1Z-eicosenyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


   

Chrysogeside D

N-(2R-hydroxy-3E-nonadecenoyl)-1-beta-D-glucopyranosyl-9-methyl-heptadecasphing-4E,8E-dienine

C43H79NO9 (753.5755)


A glucosylceramide isolated from Penicillium chrysogenum.

   

Flavicerebroside B

N-(2R-hydroxy-3E-octadecenoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E-dienine

C43H79NO9 (753.5755)


   

Flavuside B

N-(2R-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine

C43H79NO9 (753.5755)


   

HexCer 37:3;O3

N-(2S-hydroxy-3E-octadecenoyl)-1-beta-galactosyl-4E,8E-9-methyl-octadecasphingadienine

C43H79NO9 (753.5755)


   

HexCer 38:2;O2

N-(tetracosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,14Z)-1-(beta-D-glucopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide

N-[(2S,3R,4E,14Z)-1-(beta-D-glucopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,14Z)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide

N-[(2S,3R,4E,14Z)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadeca-4,14-dien-2-yl]icosanamide

C44H83NO8 (753.6118)


   

PE(20:2(11Z,14Z)/P-18:1(11Z))

PE(20:2(11Z,14Z)/P-18:1(11Z))

C43H80NO7P (753.5672)


   

HexCer 18:2;2O/20:0

HexCer 18:2;2O/20:0

C44H83NO8 (753.6118)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C43H80NO7P (753.5672)


   

HexCer 30:2;2O/8:0

HexCer 30:2;2O/8:0

C44H83NO8 (753.6118)


   

HexCer 34:2;2O/4:0

HexCer 34:2;2O/4:0

C44H83NO8 (753.6118)


   

HexCer 33:2;2O/5:0

HexCer 33:2;2O/5:0

C44H83NO8 (753.6118)


   

HexCer 35:2;2O/3:0

HexCer 35:2;2O/3:0

C44H83NO8 (753.6118)


   

HexCer 32:2;2O/6:0

HexCer 32:2;2O/6:0

C44H83NO8 (753.6118)


   

HexCer 31:2;2O/7:0

HexCer 31:2;2O/7:0

C44H83NO8 (753.6118)


   

HexCer 29:2;2O/9:0

HexCer 29:2;2O/9:0

C44H83NO8 (753.6118)


   

HexCer 8:0;2O/30:2

HexCer 8:0;2O/30:2

C44H83NO8 (753.6118)


   

HexCer 36:2;2O/2:0

HexCer 36:2;2O/2:0

C44H83NO8 (753.6118)


   

HexCer 8:1;2O/30:1

HexCer 8:1;2O/30:1

C44H83NO8 (753.6118)


   

NAGly 22:3/24:2

NAGly 22:3/24:2

C48H83NO5 (753.6271)


   

NAGly 26:4/20:1

NAGly 26:4/20:1

C48H83NO5 (753.6271)


   

NAGly 22:5/24:0

NAGly 22:5/24:0

C48H83NO5 (753.6271)


   

NAGly 22:1/24:4

NAGly 22:1/24:4

C48H83NO5 (753.6271)


   

NAGly 24:0/22:5

NAGly 24:0/22:5

C48H83NO5 (753.6271)


   

NAGly 26:3/20:2

NAGly 26:3/20:2

C48H83NO5 (753.6271)


   

NAGly 20:1/26:4

NAGly 20:1/26:4

C48H83NO5 (753.6271)


   

NAGly 26:1/20:4

NAGly 26:1/20:4

C48H83NO5 (753.6271)


   

NAGly 24:4/22:1

NAGly 24:4/22:1

C48H83NO5 (753.6271)


   

NAGly 24:1/22:4

NAGly 24:1/22:4

C48H83NO5 (753.6271)


   

NAGly 20:4/26:1

NAGly 20:4/26:1

C48H83NO5 (753.6271)


   

NAGly 22:4/24:1

NAGly 22:4/24:1

C48H83NO5 (753.6271)


   

NAGly 20:3/26:2

NAGly 20:3/26:2

C48H83NO5 (753.6271)


   

NAGly 24:5/22:0

NAGly 24:5/22:0

C48H83NO5 (753.6271)


   

NAGly 24:2/22:3

NAGly 24:2/22:3

C48H83NO5 (753.6271)


   

NAGly 24:3/22:2

NAGly 24:3/22:2

C48H83NO5 (753.6271)


   

NAGly 20:5/26:0

NAGly 20:5/26:0

C48H83NO5 (753.6271)


   

NAGly 26:5/20:0

NAGly 26:5/20:0

C48H83NO5 (753.6271)


   

NAGly 26:2/20:3

NAGly 26:2/20:3

C48H83NO5 (753.6271)


   

HexCer 27:2;2O/11:0

HexCer 27:2;2O/11:0

C44H83NO8 (753.6118)


   

HexCer 12:2;2O/26:0

HexCer 12:2;2O/26:0

C44H83NO8 (753.6118)


   

HexCer 28:2;2O/10:0

HexCer 28:2;2O/10:0

C44H83NO8 (753.6118)


   

HexCer 21:1;2O/17:1

HexCer 21:1;2O/17:1

C44H83NO8 (753.6118)


   

HexCer 22:1;2O/16:1

HexCer 22:1;2O/16:1

C44H83NO8 (753.6118)


   

HexCer 16:0;2O/22:2

HexCer 16:0;2O/22:2

C44H83NO8 (753.6118)


   

HexCer 10:0;2O/28:2

HexCer 10:0;2O/28:2

C44H83NO8 (753.6118)


   

HexCer 21:0;2O/17:2

HexCer 21:0;2O/17:2

C44H83NO8 (753.6118)


   

HexCer 10:1;2O/28:1

HexCer 10:1;2O/28:1

C44H83NO8 (753.6118)


   

HexCer 16:1;2O/22:1

HexCer 16:1;2O/22:1

C44H83NO8 (753.6118)


   

HexCer 14:1;2O/24:1

HexCer 14:1;2O/24:1

C44H83NO8 (753.6118)


   

HexCer 12:0;2O/26:2

HexCer 12:0;2O/26:2

C44H83NO8 (753.6118)


   

HexCer 14:0;2O/24:2

HexCer 14:0;2O/24:2

C44H83NO8 (753.6118)


   

HexCer 19:0;2O/19:2

HexCer 19:0;2O/19:2

C44H83NO8 (753.6118)


   

HexCer 17:0;2O/21:2

HexCer 17:0;2O/21:2

C44H83NO8 (753.6118)


   

HexCer 22:0;2O/16:2

HexCer 22:0;2O/16:2

C44H83NO8 (753.6118)


   

HexCer 17:1;2O/21:1

HexCer 17:1;2O/21:1

C44H83NO8 (753.6118)


   

HexCer 25:1;2O/13:1

HexCer 25:1;2O/13:1

C44H83NO8 (753.6118)


   

HexCer 12:1;2O/26:1

HexCer 12:1;2O/26:1

C44H83NO8 (753.6118)


   

HexCer 13:2;2O/25:0

HexCer 13:2;2O/25:0

C44H83NO8 (753.6118)


   

HexCer 20:0;2O/18:2

HexCer 20:0;2O/18:2

C44H83NO8 (753.6118)


   

HexCer 20:1;2O/18:1

HexCer 20:1;2O/18:1

C44H83NO8 (753.6118)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (26Z,29Z,32Z,35Z)-octatriaconta-26,29,32,35-tetraenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (26Z,29Z,32Z,35Z)-octatriaconta-26,29,32,35-tetraenoate

C43H80NO7P (753.5672)


   

HexCer 21:3;2O/16:0;O

HexCer 21:3;2O/16:0;O

C43H79NO9 (753.5755)


   

HexCer 18:2;2O/19:1;O

HexCer 18:2;2O/19:1;O

C43H79NO9 (753.5755)


   

HexCer 18:3;2O/19:0;O

HexCer 18:3;2O/19:0;O

C43H79NO9 (753.5755)


   

HexCer 22:2;2O/15:1;O

HexCer 22:2;2O/15:1;O

C43H79NO9 (753.5755)


   

HexCer 20:2;2O/17:1;O

HexCer 20:2;2O/17:1;O

C43H79NO9 (753.5755)


   

HexCer 21:2;2O/16:1;O

HexCer 21:2;2O/16:1;O

C43H79NO9 (753.5755)


   

HexCer 21:1;2O/16:2;O

HexCer 21:1;2O/16:2;O

C43H79NO9 (753.5755)


   

HexCer 17:3;2O/20:0;O

HexCer 17:3;2O/20:0;O

C43H79NO9 (753.5755)


   

HexCer 19:1;2O/18:2;O

HexCer 19:1;2O/18:2;O

C43H79NO9 (753.5755)


   

HexCer 17:1;2O/20:2;O

HexCer 17:1;2O/20:2;O

C43H79NO9 (753.5755)


   

HexCer 16:3;2O/21:0;O

HexCer 16:3;2O/21:0;O

C43H79NO9 (753.5755)


   

HexCer 20:3;2O/17:0;O

HexCer 20:3;2O/17:0;O

C43H79NO9 (753.5755)


   

HexCer 19:2;2O/18:1;O

HexCer 19:2;2O/18:1;O

C43H79NO9 (753.5755)


   

HexCer 19:3;2O/18:0;O

HexCer 19:3;2O/18:0;O

C43H79NO9 (753.5755)


   

HexCer 16:2;2O/21:1;O

HexCer 16:2;2O/21:1;O

C43H79NO9 (753.5755)


   

HexCer 22:3;2O/15:0;O

HexCer 22:3;2O/15:0;O

C43H79NO9 (753.5755)


   

HexCer 17:2;2O/20:1;O

HexCer 17:2;2O/20:1;O

C43H79NO9 (753.5755)


   

[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

C51H79NO3 (753.606)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide

C51H79NO3 (753.606)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

C51H79NO3 (753.606)


   

2-[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C51H79NO3 (753.606)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxynonan-2-yl)dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxynonan-2-yl)dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenamide

C51H79NO3 (753.606)


   

2-[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[3-icosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-icosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[3-henicosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-henicosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[3-nonadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-nonadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

2-[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H83NO8 (753.6118)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

C51H79NO3 (753.606)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

C51H79NO3 (753.606)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

C51H79NO3 (753.606)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]icosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)pentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)pentacosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)tricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)tricosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyicosanoylamino)tetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyicosanoylamino)tetracosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)icosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]tricosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]tricosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)nonadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)nonadeca-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]docosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]henicosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)octadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)octadeca-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(E)-3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]icos-4-ene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]tetracos-4-ene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]hexacos-4-ene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxydocosanoylamino)docosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxydocosanoylamino)docosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(E)-3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]docos-4-ene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)hexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)hexacosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]octadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]octadeca-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]nonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]nonadeca-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(4E,8E,12E)-3-hydroxy-2-(2-hydroxytricosanoylamino)henicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(2-hydroxytricosanoylamino)henicosa-4,8,12-triene-1-sulfonic acid

C44H83NO6S (753.5941)


   

(E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]octadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]octadec-4-ene-1-sulfonic acid

C44H83NO6S (753.5941)


   

[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-heptanoyloxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptanoyloxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] decanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] decanoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] docosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] docosanoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propan-2-yl] tetradecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propan-2-yl] tetradecanoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] (Z)-docos-13-enoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]propan-2-yl] dodecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]propan-2-yl] dodecanoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] (Z)-tetradec-9-enoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C43H80NO7P (753.5672)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-[(Z)-heptadec-9-enoxy]-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-heptadec-9-enoxy]-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-heptadecoxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptadecoxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

2-[4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C47H79NO6 (753.5907)


   

2-[4-[3-[(Z)-docos-13-enoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(Z)-docos-13-enoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C48H83NO5 (753.6271)


   

Cer 17:0;2O/13:1;(3OH)(FA 18:5)

Cer 17:0;2O/13:1;(3OH)(FA 18:5)

C48H83NO5 (753.6271)


   

Cer 17:0;2O/18:5;(3OH)(FA 13:1)

Cer 17:0;2O/18:5;(3OH)(FA 13:1)

C48H83NO5 (753.6271)


   

Cer 14:0;2O/14:0;(3OH)(FA 20:6)

Cer 14:0;2O/14:0;(3OH)(FA 20:6)

C48H83NO5 (753.6271)


   

Cer 14:0;2O/16:1;(3OH)(FA 18:5)

Cer 14:0;2O/16:1;(3OH)(FA 18:5)

C48H83NO5 (753.6271)


   

Cer 14:0;2O/15:1;(3OH)(FA 19:5)

Cer 14:0;2O/15:1;(3OH)(FA 19:5)

C48H83NO5 (753.6271)


   

Cer 16:0;2O/12:0;(3OH)(FA 20:6)

Cer 16:0;2O/12:0;(3OH)(FA 20:6)

C48H83NO5 (753.6271)


   

Cer 16:0;2O/16:3;(3OH)(FA 16:3)

Cer 16:0;2O/16:3;(3OH)(FA 16:3)

C48H83NO5 (753.6271)


   

Cer 15:0;2O/13:1;(3OH)(FA 20:5)

Cer 15:0;2O/13:1;(3OH)(FA 20:5)

C48H83NO5 (753.6271)


   

Cer 15:0;2O/16:4;(3OH)(FA 17:2)

Cer 15:0;2O/16:4;(3OH)(FA 17:2)

C48H83NO5 (753.6271)


   

HexCer 24:2;2O/14:0

HexCer 24:2;2O/14:0

C44H83NO8 (753.6118)


   

HexCer 14:2;2O/24:0

HexCer 14:2;2O/24:0

C44H83NO8 (753.6118)


   

HexCer 23:1;2O/15:1

HexCer 23:1;2O/15:1

C44H83NO8 (753.6118)


   

HexCer 17:2;2O/21:0

HexCer 17:2;2O/21:0

C44H83NO8 (753.6118)


   

HexCer 24:1;2O/14:1

HexCer 24:1;2O/14:1

C44H83NO8 (753.6118)


   

HexCer 22:2;2O/16:0

HexCer 22:2;2O/16:0

C44H83NO8 (753.6118)


   

HexCer 18:1;2O/20:1

HexCer 18:1;2O/20:1

C44H83NO8 (753.6118)


   

HexCer 25:2;2O/13:0

HexCer 25:2;2O/13:0

C44H83NO8 (753.6118)


   

HexCer 26:2;2O/12:0

HexCer 26:2;2O/12:0

C44H83NO8 (753.6118)


   

HexCer 19:1;2O/19:1

HexCer 19:1;2O/19:1

C44H83NO8 (753.6118)


   

HexCer 19:2;2O/19:0

HexCer 19:2;2O/19:0

C44H83NO8 (753.6118)


   

HexCer 16:2;2O/22:0

HexCer 16:2;2O/22:0

C44H83NO8 (753.6118)


   

HexCer 23:2;2O/15:0

HexCer 23:2;2O/15:0

C44H83NO8 (753.6118)


   

HexCer 15:2;2O/23:0

HexCer 15:2;2O/23:0

C44H83NO8 (753.6118)


   

HexCer 21:2;2O/17:0

HexCer 21:2;2O/17:0

C44H83NO8 (753.6118)


   

HexCer 18:0;2O/20:2

HexCer 18:0;2O/20:2

C44H83NO8 (753.6118)


   

HexCer 20:2;2O/18:0

HexCer 20:2;2O/18:0

C44H83NO8 (753.6118)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] (Z)-icos-11-enoate

C43H80NO7P (753.5672)


   

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] octadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] octadecanoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] (Z)-octadec-9-enoate

C43H80NO7P (753.5672)


   

[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C43H80NO7P (753.5672)


   

[2-heptadecanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptadecanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]propan-2-yl] hexadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]propan-2-yl] hexadecanoate

C43H80NO7P (753.5672)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] icosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] icosanoate

C43H80NO7P (753.5672)


   

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] (Z)-hexadec-9-enoate

C43H80NO7P (753.5672)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (4Z,7Z,10Z,13Z)-icosa-4,7,10,13-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (4Z,7Z,10Z,13Z)-icosa-4,7,10,13-tetraenoate

C43H80NO7P (753.5672)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (4Z,7Z,10Z,13Z)-docosa-4,7,10,13-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (4Z,7Z,10Z,13Z)-docosa-4,7,10,13-tetraenoate

C43H80NO7P (753.5672)


   

(18Z,21Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracosa-18,21-dienamide

(18Z,21Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracosa-18,21-dienamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docos-11-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docos-11-enamide

C44H83NO8 (753.6118)


   

(4Z,7Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadeca-4,7-dienamide

(4Z,7Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadeca-4,7-dienamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacos-4-en-2-yl]tridec-8-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacos-4-en-2-yl]tridec-8-enamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexacos-4-en-2-yl]dodec-5-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexacos-4-en-2-yl]dodec-5-enamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-4-en-2-yl]tricos-11-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-4-en-2-yl]tricos-11-enamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracos-11-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracos-11-enamide

C44H83NO8 (753.6118)


   

(10Z,12Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadeca-10,12-dienamide

(10Z,12Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadeca-10,12-dienamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-4-en-2-yl]henicos-9-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-4-en-2-yl]henicos-9-enamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-4-en-2-yl]hexadec-7-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-4-en-2-yl]hexadec-7-enamide

C44H83NO8 (753.6118)


   

(14Z,16Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docosa-14,16-dienamide

(14Z,16Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docosa-14,16-dienamide

C44H83NO8 (753.6118)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadec-11-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadec-11-enamide

C44H83NO8 (753.6118)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (8E,11E,14E)-icosa-8,11,14-trienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (8E,11E,14E)-icosa-8,11,14-trienoate

C43H80NO7P (753.5672)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-8-en-2-yl]docos-13-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-8-en-2-yl]docos-13-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]tetracosanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]tetracosanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-8-en-2-yl]octadec-9-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-8-en-2-yl]octadec-9-enamide

C44H83NO8 (753.6118)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (5E,8E,11E)-icosa-5,8,11-trienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (5E,8E,11E)-icosa-5,8,11-trienoate

C43H80NO7P (753.5672)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]icosanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]icosanamide

C44H83NO8 (753.6118)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-4-en-2-yl]heptadec-9-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-4-en-2-yl]heptadec-9-enamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-8-en-2-yl]tetracos-15-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-8-en-2-yl]tetracos-15-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,6-dien-2-yl]docosanamide

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,6-dien-2-yl]docosanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-4-en-2-yl]hexadec-9-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-4-en-2-yl]hexadec-9-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadeca-4,8-dien-2-yl]henicosanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadeca-4,8-dien-2-yl]henicosanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-8-en-2-yl]icos-11-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-8-en-2-yl]icos-11-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,8-dien-2-yl]hexadecanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,8-dien-2-yl]hexadecanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]icos-11-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]icos-11-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,14E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,14-dien-2-yl]icosanamide

N-[(2S,3R,4E,14E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,14-dien-2-yl]icosanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-8-en-2-yl]heptadec-9-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-8-en-2-yl]heptadec-9-enamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-8-en-2-yl]hexadec-9-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-8-en-2-yl]hexadec-9-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,6-dien-2-yl]tricosanamide

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,6-dien-2-yl]tricosanamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadeca-4,8-dien-2-yl]nonadecanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadeca-4,8-dien-2-yl]nonadecanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docos-13-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docos-13-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8-dien-2-yl]docosanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8-dien-2-yl]docosanamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]tricosanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]tricosanamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracos-15-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracos-15-enamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicosa-4,8-dien-2-yl]heptadecanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicosa-4,8-dien-2-yl]heptadecanamide

C44H83NO8 (753.6118)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C43H80NO7P (753.5672)


   

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]tetracosanamide

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]tetracosanamide

C44H83NO8 (753.6118)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-4,8-dien-2-yl]octadecanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-4,8-dien-2-yl]octadecanamide

C44H83NO8 (753.6118)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C43H80NO7P (753.5672)


   

(9E,12E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadeca-9,12-dienamide

(9E,12E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadeca-9,12-dienamide

C44H83NO8 (753.6118)


   

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadec-9-enamide

(E)-N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadec-9-enamide

C44H83NO8 (753.6118)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(18Z,21Z)-tetracosa-18,21-dienoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(18Z,21Z)-tetracosa-18,21-dienoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tricosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tricosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[3-hydroxy-2-[[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhenicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhenicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]icosoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]icosoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydocosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydocosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[3-hydroxy-2-[[(18Z,21Z,24Z,27Z)-triaconta-18,21,24,27-tetraenoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(18Z,21Z,24Z,27Z)-triaconta-18,21,24,27-tetraenoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E,12E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[[(4E,8E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O6P+ (753.591)


   

1-(1Z-octadecenyl)-2-(8Z,11Z,14Z-icosatrienoyl)-sn-glycero-3-phosphoethanolamine

1-(1Z-octadecenyl)-2-(8Z,11Z,14Z-icosatrienoyl)-sn-glycero-3-phosphoethanolamine

C43H80NO7P (753.5672)


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-octadecenyl and (8Z,11Z,14Z)-icosatrienoyl respectively.

   

PC(P-18:1(9Z)/P-18:1(9Z))

PC(P-18:1(9Z)/P-18:1(9Z))

C44H84NO6P (753.6036)


   

PC(P-18:1(11Z)/P-18:1(11Z))

PC(P-18:1(11Z)/P-18:1(11Z))

C44H84NO6P (753.6036)


   

PC(P-18:1(11Z)/P-18:1(9Z))

PC(P-18:1(11Z)/P-18:1(9Z))

C44H84NO6P (753.6036)


   

PC(P-18:1(9Z)/P-18:1(11Z))

PC(P-18:1(9Z)/P-18:1(11Z))

C44H84NO6P (753.6036)


   

PE(20:3(5Z,8Z,11Z)/P-18:0)

PE(20:3(5Z,8Z,11Z)/P-18:0)

C43H80NO7P (753.5672)


   

beta-D-glucosyl-(1<->1)-N-icosanoyl-(4E,14Z)-sphingadienine

beta-D-glucosyl-(1<->1)-N-icosanoyl-(4E,14Z)-sphingadienine

C44H83NO8 (753.6118)


A beta-D-glucosylceramide obtained by formal condensation of the carboxy group of icosanoic acid with the amino group of beta-D-glucosyl-(1<->1)-(4E,14Z)-sphingadienine.

   

beta-D-galactosyl-(1<->1)-N-icosanoyl-(4E,14Z)-sphingadienine

beta-D-galactosyl-(1<->1)-N-icosanoyl-(4E,14Z)-sphingadienine

C44H83NO8 (753.6118)


A galactosylceramide obtained by formal condensation of the carboxy group of icosanoic acid with the amino group of beta-D-galactosyl-(1<->1)-(4E,14Z)-sphingadienine.

   

MePC(34:4)

MePC(14:0(1)_20:4)

C43H80NO7P (753.5672)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(37:3)

Hex1Cer(d19:2_18:1(1+O))

C43H79NO9 (753.5755)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(36:4)

dMePE(16:0(1)_20:4)

C43H80NO7P (753.5672)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(38:2)

Hex1Cer(d20:2_18:0)

C44H83NO8 (753.6118)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   

PC P-18:1/17:2 or PC O-18:2/17:2

PC P-18:1/17:2 or PC O-18:2/17:2

C43H80NO7P (753.5672)


   
   

PC P-35:3 or PC O-35:4

PC P-35:3 or PC O-35:4

C43H80NO7P (753.5672)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PE P-16:0/22:3 or PE O-16:1/22:3

PE P-16:0/22:3 or PE O-16:1/22:3

C43H80NO7P (753.5672)


   
   

PE P-16:1/22:2 or PE O-16:2/22:2

PE P-16:1/22:2 or PE O-16:2/22:2

C43H80NO7P (753.5672)


   
   

PE P-18:0/20:3 or PE O-18:1/20:3

PE P-18:0/20:3 or PE O-18:1/20:3

C43H80NO7P (753.5672)


   
   

PE P-18:1/20:2 or PE O-18:2/20:2

PE P-18:1/20:2 or PE O-18:2/20:2

C43H80NO7P (753.5672)


   
   

PE P-20:0/18:3 or PE O-20:1/18:3

PE P-20:0/18:3 or PE O-20:1/18:3

C43H80NO7P (753.5672)


   
   

PE P-20:1/18:2 or PE O-20:2/18:2

PE P-20:1/18:2 or PE O-20:2/18:2

C43H80NO7P (753.5672)


   
   

PE P-38:3 or PE O-38:4

PE P-38:3 or PE O-38:4

C43H80NO7P (753.5672)


   

CerP 18:1;O2/26:2

CerP 18:1;O2/26:2

C44H84NO6P (753.6036)


   

CerP 18:2;O2/26:1

CerP 18:2;O2/26:1

C44H84NO6P (753.6036)


   

CerP 20:2;O2/24:1

CerP 20:2;O2/24:1

C44H84NO6P (753.6036)


   

CerP 22:1;O2/22:2

CerP 22:1;O2/22:2

C44H84NO6P (753.6036)


   

CerP 22:2;O2/22:1

CerP 22:2;O2/22:1

C44H84NO6P (753.6036)


   
   

Cer 9:0;O2/42:12

Cer 9:0;O2/42:12

C51H79NO3 (753.606)


   

GalCer 14:1;O2/24:1

GalCer 14:1;O2/24:1

C44H83NO8 (753.6118)


   

GalCer 14:2;O2/24:0

GalCer 14:2;O2/24:0

C44H83NO8 (753.6118)


   

GalCer 15:2;O2/22:1;O

GalCer 15:2;O2/22:1;O

C43H79NO9 (753.5755)


   

GalCer 15:2;O2/23:0

GalCer 15:2;O2/23:0

C44H83NO8 (753.6118)


   

GalCer 16:0;O2/22:2

GalCer 16:0;O2/22:2

C44H83NO8 (753.6118)


   

GalCer 16:1;O2/22:1

GalCer 16:1;O2/22:1

C44H83NO8 (753.6118)


   

GalCer 16:2;O2/22:0

GalCer 16:2;O2/22:0

C44H83NO8 (753.6118)


   

GalCer 17:0;O3/20:3

GalCer 17:0;O3/20:3

C43H79NO9 (753.5755)


   

GalCer 17:2;O2/20:1;O

GalCer 17:2;O2/20:1;O

C43H79NO9 (753.5755)


   

GalCer 17:2;O2/21:0

GalCer 17:2;O2/21:0

C44H83NO8 (753.6118)


   

GalCer 18:0;O2/20:2

GalCer 18:0;O2/20:2

C44H83NO8 (753.6118)


   

GalCer 18:1;O2/20:1

GalCer 18:1;O2/20:1

C44H83NO8 (753.6118)


   

GalCer 18:2;O2/20:0

GalCer 18:2;O2/20:0

C44H83NO8 (753.6118)


   

GalCer 19:0;O3/18:3

GalCer 19:0;O3/18:3

C43H79NO9 (753.5755)


   

GalCer 19:2;O2/18:1;O

GalCer 19:2;O2/18:1;O

C43H79NO9 (753.5755)


   

GalCer 19:2;O2/19:0

GalCer 19:2;O2/19:0

C44H83NO8 (753.6118)


   

GalCer 20:0;O2/18:2

GalCer 20:0;O2/18:2

C44H83NO8 (753.6118)


   

GalCer 20:1;O2/18:1

GalCer 20:1;O2/18:1

C44H83NO8 (753.6118)


   

GalCer 20:2;O2/18:0

GalCer 20:2;O2/18:0

C44H83NO8 (753.6118)


   

GalCer 21:0;O2/17:2

GalCer 21:0;O2/17:2

C44H83NO8 (753.6118)


   

GalCer 21:1;O2/17:1

GalCer 21:1;O2/17:1

C44H83NO8 (753.6118)


   

GalCer 21:2;O2/17:0

GalCer 21:2;O2/17:0

C44H83NO8 (753.6118)


   

GalCer 22:1;O2/16:1

GalCer 22:1;O2/16:1

C44H83NO8 (753.6118)


   

GalCer 22:2;O2/16:0

GalCer 22:2;O2/16:0

C44H83NO8 (753.6118)


   

GalCer 37:3;O2;O

GalCer 37:3;O2;O

C43H79NO9 (753.5755)


   

GalCer 37:3;O3

GalCer 37:3;O3

C43H79NO9 (753.5755)


   

GalCer 38:2;O2

GalCer 38:2;O2

C44H83NO8 (753.6118)


   

GlcCer 14:1;O2/24:1

GlcCer 14:1;O2/24:1

C44H83NO8 (753.6118)


   

GlcCer 14:2;O2/24:0

GlcCer 14:2;O2/24:0

C44H83NO8 (753.6118)


   

GlcCer 14:2;O2(4E,6E)/24:0

GlcCer 14:2;O2(4E,6E)/24:0

C44H83NO8 (753.6118)


   

GlcCer 15:2;O2/22:1;O

GlcCer 15:2;O2/22:1;O

C43H79NO9 (753.5755)


   

GlcCer 15:2;O2/23:0

GlcCer 15:2;O2/23:0

C44H83NO8 (753.6118)


   

GlcCer 16:0;O2/22:2

GlcCer 16:0;O2/22:2

C44H83NO8 (753.6118)


   

GlcCer 16:1;O2/22:1

GlcCer 16:1;O2/22:1

C44H83NO8 (753.6118)


   

GlcCer 16:2;O2/22:0

GlcCer 16:2;O2/22:0

C44H83NO8 (753.6118)


   

GlcCer 16:2;O2(4E,6E)/22:0

GlcCer 16:2;O2(4E,6E)/22:0

C44H83NO8 (753.6118)


   

GlcCer 17:0;O3/20:3

GlcCer 17:0;O3/20:3

C43H79NO9 (753.5755)


   

GlcCer 17:2;O2/20:1;O

GlcCer 17:2;O2/20:1;O

C43H79NO9 (753.5755)


   

GlcCer 17:2;O2/21:0

GlcCer 17:2;O2/21:0

C44H83NO8 (753.6118)


   

GlcCer 18:0;O2/20:2

GlcCer 18:0;O2/20:2

C44H83NO8 (753.6118)


   

GlcCer 18:1;O2/20:1

GlcCer 18:1;O2/20:1

C44H83NO8 (753.6118)


   

GlcCer 18:2;O2/20:0

GlcCer 18:2;O2/20:0

C44H83NO8 (753.6118)


   

GlcCer 19:0;O3/18:3

GlcCer 19:0;O3/18:3

C43H79NO9 (753.5755)


   

GlcCer 19:2;O2/18:1;O

GlcCer 19:2;O2/18:1;O

C43H79NO9 (753.5755)


   

GlcCer 19:2;O2/19:0

GlcCer 19:2;O2/19:0

C44H83NO8 (753.6118)


   

GlcCer 20:0;O2/18:2

GlcCer 20:0;O2/18:2

C44H83NO8 (753.6118)


   

GlcCer 20:1;O2/18:1

GlcCer 20:1;O2/18:1

C44H83NO8 (753.6118)


   

GlcCer 20:2;O2/18:0

GlcCer 20:2;O2/18:0

C44H83NO8 (753.6118)


   

GlcCer 21:0;O2/17:2

GlcCer 21:0;O2/17:2

C44H83NO8 (753.6118)


   

GlcCer 21:1;O2/17:1

GlcCer 21:1;O2/17:1

C44H83NO8 (753.6118)


   

GlcCer 21:2;O2/17:0

GlcCer 21:2;O2/17:0

C44H83NO8 (753.6118)


   

GlcCer 22:1;O2/16:1

GlcCer 22:1;O2/16:1

C44H83NO8 (753.6118)


   

GlcCer 22:2;O2/16:0

GlcCer 22:2;O2/16:0

C44H83NO8 (753.6118)


   

GlcCer 37:3;O2;O

GlcCer 37:3;O2;O

C43H79NO9 (753.5755)


   

GlcCer 37:3;O3

GlcCer 37:3;O3

C43H79NO9 (753.5755)


   

GlcCer 38:2;O2

GlcCer 38:2;O2

C44H83NO8 (753.6118)


   

HexCer 14:2;O2/24:0

HexCer 14:2;O2/24:0

C44H83NO8 (753.6118)


   

HexCer 15:2;O2/22:1;2OH

HexCer 15:2;O2/22:1;2OH

C43H79NO9 (753.5755)


   

HexCer 15:2;O2/22:1;3OH

HexCer 15:2;O2/22:1;3OH

C43H79NO9 (753.5755)


   

HexCer 15:2;O2/22:1;O

HexCer 15:2;O2/22:1;O

C43H79NO9 (753.5755)


   

HexCer 15:2;O2/23:0

HexCer 15:2;O2/23:0

C44H83NO8 (753.6118)


   

HexCer 16:0;O2/22:2

HexCer 16:0;O2/22:2

C44H83NO8 (753.6118)


   

HexCer 16:1;O2/22:1

HexCer 16:1;O2/22:1

C44H83NO8 (753.6118)


   

HexCer 16:2;O2/21:1;O

HexCer 16:2;O2/21:1;O

C43H79NO9 (753.5755)


   

HexCer 16:2;O2/22:0

HexCer 16:2;O2/22:0

C44H83NO8 (753.6118)


   

HexCer 17:0;O3/20:3

HexCer 17:0;O3/20:3

C43H79NO9 (753.5755)


   

HexCer 17:2;O2/20:1;2OH

HexCer 17:2;O2/20:1;2OH

C43H79NO9 (753.5755)


   

HexCer 17:2;O2/20:1;3OH

HexCer 17:2;O2/20:1;3OH

C43H79NO9 (753.5755)


   

HexCer 17:2;O2/20:1;O

HexCer 17:2;O2/20:1;O

C43H79NO9 (753.5755)


   

HexCer 17:2;O2/21:0

HexCer 17:2;O2/21:0

C44H83NO8 (753.6118)


   

HexCer 18:0;O2/20:2

HexCer 18:0;O2/20:2

C44H83NO8 (753.6118)


   

HexCer 18:1;O2/20:1

HexCer 18:1;O2/20:1

C44H83NO8 (753.6118)


   

HexCer 18:2;O2/20:0

HexCer 18:2;O2/20:0

C44H83NO8 (753.6118)


   

HexCer 19:0;O3/18:3

HexCer 19:0;O3/18:3

C43H79NO9 (753.5755)


   

HexCer 19:2;O2/18:1;2OH

HexCer 19:2;O2/18:1;2OH

C43H79NO9 (753.5755)


   

HexCer 19:2;O2/18:1;3OH

HexCer 19:2;O2/18:1;3OH

C43H79NO9 (753.5755)


   

HexCer 19:2;O2/18:1;O

HexCer 19:2;O2/18:1;O

C43H79NO9 (753.5755)


   

HexCer 19:2;O2/19:0

HexCer 19:2;O2/19:0

C44H83NO8 (753.6118)


   

HexCer 20:0;O2/18:2

HexCer 20:0;O2/18:2

C44H83NO8 (753.6118)


   

HexCer 20:1;O2/18:1

HexCer 20:1;O2/18:1

C44H83NO8 (753.6118)


   

HexCer 20:2;O2/18:0

HexCer 20:2;O2/18:0

C44H83NO8 (753.6118)


   

HexCer 21:0;O2/17:2

HexCer 21:0;O2/17:2

C44H83NO8 (753.6118)


   

HexCer 21:1;O2/17:1

HexCer 21:1;O2/17:1

C44H83NO8 (753.6118)


   

HexCer 21:2;O2/17:0

HexCer 21:2;O2/17:0

C44H83NO8 (753.6118)


   

HexCer 22:1;O2/16:1

HexCer 22:1;O2/16:1

C44H83NO8 (753.6118)


   

HexCer 22:2;O2/16:0

HexCer 22:2;O2/16:0

C44H83NO8 (753.6118)


   

HexCer 37:3;O2;O

HexCer 37:3;O2;O

C43H79NO9 (753.5755)


   
   

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl)octadec-3-enimidic acid

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl)octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,8-dien-2-yl]nonadec-3-enimidic acid

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,8-dien-2-yl]nonadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(2r,3e)-2-hydroxy-n-[(2s,3s,4e,9e)-3-hydroxy-10-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,9-dien-2-yl]octadec-3-enimidic acid

(2r,3e)-2-hydroxy-n-[(2s,3s,4e,9e)-3-hydroxy-10-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,9-dien-2-yl]octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(2s,3e)-2-hydroxy-n-[(2r,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

(2s,3e)-2-hydroxy-n-[(2r,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

2-hydroxy-n-(3-hydroxy-10-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,9-dien-2-yl)octadec-3-enimidic acid

2-hydroxy-n-(3-hydroxy-10-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,9-dien-2-yl)octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,5r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,5r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}icosa-4,8-dien-2-yl]hexadec-3-enimidic acid

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}icosa-4,8-dien-2-yl]hexadec-3-enimidic acid

C43H79NO9 (753.5755)


   

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8,10-trien-2-yl)octadecanimidic acid

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8,10-trien-2-yl)octadecanimidic acid

C43H79NO9 (753.5755)


   

(13z)-n-[(2s,3r,4e)-3-hydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadec-4-en-2-yl]docos-13-enimidic acid

(13z)-n-[(2s,3r,4e)-3-hydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadec-4-en-2-yl]docos-13-enimidic acid

C44H83NO8 (753.6118)


   

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(2r)-2-hydroxy-n-[(2s,3r,4e,8e,10e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8,10-trien-2-yl]octadecanimidic acid

(2r)-2-hydroxy-n-[(2s,3r,4e,8e,10e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8,10-trien-2-yl]octadecanimidic acid

C43H79NO9 (753.5755)


   

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,7e)-3-hydroxy-8-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,7-dien-2-yl]nonadec-3-enimidic acid

(2r,3e)-2-hydroxy-n-[(2s,3r,4e,7e)-3-hydroxy-8-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,7-dien-2-yl]nonadec-3-enimidic acid

C43H79NO9 (753.5755)


   

(3e)-2-hydroxy-n-[(4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

(3e)-2-hydroxy-n-[(4e,8e)-3-hydroxy-9-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enimidic acid

C43H79NO9 (753.5755)


   

2-hydroxy-n-(3-hydroxy-8-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,7-dien-2-yl)nonadec-3-enimidic acid

2-hydroxy-n-(3-hydroxy-8-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,7-dien-2-yl)nonadec-3-enimidic acid

C43H79NO9 (753.5755)


   

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}icosa-4,8-dien-2-yl)hexadec-3-enimidic acid

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}icosa-4,8-dien-2-yl)hexadec-3-enimidic acid

C43H79NO9 (753.5755)


   

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,8-dien-2-yl)nonadec-3-enimidic acid

2-hydroxy-n-(3-hydroxy-9-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-4,8-dien-2-yl)nonadec-3-enimidic acid

C43H79NO9 (753.5755)


   

n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadec-4-en-2-yl)docos-13-enimidic acid

n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadec-4-en-2-yl)docos-13-enimidic acid

C44H83NO8 (753.6118)